[HTML][HTML] More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy

M Flores-Leon, TF Outeiro - Acta neuropathologica, 2023 - Springer
The accumulation of proteinaceous inclusions in the brain is a common feature among
neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), and …

[HTML][HTML] Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues

E Menozzi, M Toffoli, AHV Schapira - Pharmacology & therapeutics, 2023 - Elsevier
The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (GCase), which is
involved in sphingolipid metabolism. Biallelic variants in GBA1 cause Gaucher disease …

[HTML][HTML] Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease

Y Zhou, Y Wang, J Wan, Y Zhao, H Pan, Q Zeng… - npj Parkinson's …, 2023 - nature.com
GBA1 variants are important risk factors for Parkinson's disease (PD). Most studies
assessing GBA1-related PD risk have been performed in European-derived populations …

The lysosomal β-glucocerebrosidase strikes mitochondria: Implications for Parkinson's therapeutics

JC Rubilar, TF Outeiro, AD Klein - Brain, 2024 - academic.oup.com
Parkinson's disease (PD) is a neurodegenerative disorder primarily known for typical motor
features that arise due to the loss of dopaminergic neurons in the substantia nigra. However …

[HTML][HTML] Mechanisms of Glucocerebrosidase Dysfunction in Parkinson's Disease

D Chatterjee, D Krainc - Journal of molecular biology, 2023 - Elsevier
Beta-glucocerebrosidase is a lysosomal hydrolase, encoded by GBA1 that represents the
most common risk gene associated with Parkinson's disease (PD) and Lewy Body …

Frequency of Hereditary and GBA1‐Related Parkinsonism in Latin America: A Systematic Review and Meta‐Analysis

P Saffie Awad, D Teixeira‐dos‐Santos… - Movement …, 2024 - Wiley Online Library
Background Identifying hereditary parkinsonism is valuable for diagnosis, genetic
counseling, patient prioritization in trials, and studying the disease for personalized …

Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort

M Avenali, R Zangaglia, G Cuconato… - Journal of Neurology …, 2024 - jnnp.bmj.com
Background GBA variants increase the risk of developing Parkinson disease (PD) and
influence its outcome. Deep brain stimulation (DBS) is a recognised therapeutic option for …

[HTML][HTML] Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study

M Toffoli, H Chohan, S Mullin, A Jesuthasan… - Neurobiology of …, 2023 - Elsevier
Background Variants in the GBA1 gene cause the lysosomal storage disorder Gaucher
disease (GD). They are also risk factors for Parkinson's disease (PD), and modify the …

The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1

EK Gustavsson, S Sethi, Y Gao, JW Brenton… - Science …, 2024 - science.org
Mutations in GBA1 cause Gaucher disease and are the most important genetic risk factor for
Parkinson's disease. However, analysis of transcription at this locus is complicated by its …

The genetic drivers of juvenile, Young, and early‐onset Parkinson's disease in India

SV Andrews, PL Kukkle, R Menon… - Movement …, 2024 - Wiley Online Library
Background Recent studies have advanced our understanding of the genetic drivers of
Parkinson's disease (PD). Rare variants in more than 20 genes are considered causal for …